Best New Migraine Medications and Treatments — Migraine Again
Jun 6, 2025 · Approved by the FDA in January 2025 for the acute treatment of migraine in adults, Symbravo combines two drugs that have been on the market for years: rizatriptan (Maxalt) …
FDA Approves Brekiya, First and Only DHE Autoinjector, for ...
May 15, 2025 · Unlike migraines, cluster headaches occur as frequent attacks (referred to as “clusters”), which result in intense pain in or around the eye or 1 side of the head. These …
FDA Approves Symbravo for Acute Treatment of Migraine in ...
Last updated on Feb 6, 2025. By Lori Solomon HealthDay Reporter. WEDNESDAY, Feb. 5, 2025 -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and …
Amneal Receives U.S. FDA Approval for Brekiya® - GlobeNewswire
May 15, 2025 · DHE can be used at any point during a migraine attack, and may protect patients from headache recurrence. 1, 3,4 Approximately 39 million Americans are living with migraine …
Amneal Pharmaceuticals, Inc. - Amneal Receives U.S. FDA ...
May 15, 2025 · Brekiya ® becomes the first and only DHE autoinjector that allows patients to self-administer the same medication used in hospitals in a ready-to-use form Product will be …